Rofecoxib versus magnesium sulfate to arrest preterm labor: A randomized trial

Obstetrics and Gynecology

Volumn 103, Issue 5 I, 2004, Pages 923-930

  McWhorter, Jeannie ^b   Carlan, S J ^a   O'Leary, Timothy D ^b   Richichi, Kris ^b   O'Brien, W F ^b  

^a ORLANDO HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CYCLOOXYGENASE 2 INHIBITOR; FIBRONECTIN; MAGNESIUM SULFATE; PLACEBO; ROFECOXIB; UTERUS SPASMOLYTIC AGENT; LACTONE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONE;

ADULT; AMNIOCENTESIS; AMNION FLUID; ANALYSIS OF VARIANCE; ARTICLE; BRAIN HEMORRHAGE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSPNEA; FEMALE; FLUSHING; HEADACHE; HEARTBURN; HUMAN; INDIGESTION; INJECTION SITE REACTION; LENGTH OF STAY; LETHARGY; MAJOR CLINICAL STUDY; NAUSEA; NECROTIZING ENTEROCOLITIS; NEISSERIA GONORRHOEAE; NEWBORN; NEWBORN SEPSIS; OUTCOMES RESEARCH; PREMATURE LABOR; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; RESPIRATORY DISTRESS SYNDROME; SAMPLE SIZE; SIDE EFFECT; STREPTOCOCCUS AGALACTIAE; STUDENT T TEST; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX DILATATION; COMPARATIVE STUDY; ORAL DRUG ADMINISTRATION; PREGNANCY; TIME;

ADMINISTRATION, ORAL; ADULT; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; LACTONES; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; SULFONES; TIME FACTORS; TOCOLYTIC AGENTS;

EID: 2942753914     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000124784.48287.15     Document Type: Article

References (41)

1. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419-24.
2. Goldenberg RL. The management of preterm labor [review]. Obstet Gynecol 2002;100:1020-37.
3. O'Brien WF. The role of prostaglandins in labor and delivery [review]. Clin Perinatol 1995;22:973-84.
4. Olson DM, Mijovic JE, Sadowsky DW. Control of human parturition [review]. Semin Perinatol 1995;19:52-63.
5. Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol 1974; 44:787-92.
6. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2 [review]. N Engl J Med 2001;345: 433-42.
7. Slater D, Allport V, Bennett P. Changes in the expression of the type-2 but not the type-1 cyclo-oxygenase enzyme in chorion-decidua with the onset of labour. Br J Obstet Gynaecol 1998;105:745-8.
8. Fuentes A, Spaziani EP, O'Brien WF. The expression of cyclooxygenase-2 (COX-2) in amnion and decidua following spontaneous labor. Prostaglandins 1996;52:261-7.
9. Hayes EC, Rock JA. COX-2 inhibitors and their role in gynecology [review]. Obstet Gynecol Surv 2002;57: 768-80.
10. Petrie RH. Preterm parturition: tocolysis using magnesium sulfate [review]. Semin Perinatol 1981;5:266-73.
11. Nochimson D, Petrie R, Shah B, Pampati N, Brunelle D. Comparison of conservative and dynamic management of premature rupture of the membranes/premature labor syndrome: new approaches to delivery of which may minimize the need for intensive care. Clin Perinatol 1980; 7:17-31.
12. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part II. Double-blind study. J Perinat Med 1984;12: 25-9.
13. Perkins D, Kniss D. Tumor necrosis factor-alpha promotes sustained cyclooxygenase-2 expression: attenuation by dexamethasone and NSAIDs. Prostaglandins 1997;54: 727-43.
14. Sawdy RJ, Slater DM, Dermes WJ, Sullivan MH, Bennett PR. The roles of the cyclo-oxygenases types one and two in prostaglandin synthesis in human fetal membranes at term. Placenta 2000;21:54-7.
15. 2 in cultured human amnion cells. Gynecol Obstet Invest 1989;28:123-6.
16. Rauk PN, Chiao JP. Interleukin-1 stimulates human uterine prostaglandin production through induction of cyclooxygenase-2 expression. Am J Reprod Immunol 2000;43: 152-9.
17. Slater DM, Berger LC, Newton R, Moore GE, Bennett PR. Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. Am J Obstet Gynecol 1995;172: 77-82.
18. Habermehl DA, Janowiak MA, Vagnoni KE, Bird IM, Magness RR. Endothelial vasodilator production by uterine and systemic arteries. IV. Cyclooxygenase isoform expression during the ovarian cycle and pregnancy in sheep. Biol Reprod 2000;62:781-8.
19. Sawdy R, Slater D, Fisk N, Edmonds DK, Bennett P. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 1997;350:265-66.
20. Slattery MM, Friel AM, Healy DG, Morrison JJ. Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro. Obstet Gynecol 2001;98:563-9.
21. Bukowski R, Saade GR. New developments in the management of preterm labor [review]. Semin Perinatol. 2001; 25:272-94.
22. Shellhaas CS, Iams JD. The diagnosis and management of preterm labor [review]. J Obstet Gynaecol Res 2001;6: 305-11.
23. Lee PR, Kim SR, Jung BK, Kim KR, Chung JY, Won HS, Kim A. Therapeutic effect of cyclo-oxygenase inhibitors with different isoform selectivity in lipopolysaccharide-induced preterm birth in mice. Am J Obstet Gynecol 2003;189:261-6.
24. Guerguerian AM, Hardy P, Bhattacharya M, Olley P, Clyman RI, Fouron JC, et al. Expression of cyclooxygenase in ductus arteriosis of fetal and newborn pigs. Am J Obstet Gynecol 1998;179:1618-26.
25. Loftin CD, Trivedi DB, Langenbach R. Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus. Clin Invest 2002; 110:549-57.
26. Holmes RP, Stone PR. Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. Obstet Gynecol 2000;96:810-1.
27. Locatelli A, Vergani P, Bellini P, Strobelt N, Ghidini A. Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin? BJOG 2001; 108:325-6.
28. Peruzzi L, Gianoglio B, Porcellini MG, Coppo R. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet 1999;354:1615.
29. Crowther CA, Moore V. Magnesium for preventing preterm birth after threatened preterm labour [review]. Cochrane Database Syst Rev 2000;2:CD000940.
30. Steer CM, Petrie RH. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 1977;129:1-4.
31. Hollander DI, Nagey DA, Pupkin MJ. Magnesium sulfate and ritodrine hydrochloride: a randomized comparison. Am J Obstet Gynecol 1987;156:631-7.
32. Clock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993; 169:960-4.
33. Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad A, Das A, et al. The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth. Am J Obstet Gynecol 2001;185:643-51.
34. Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995;173:141-5.
35. Goldenberg RL, Rouse DJ. The prevention of premature birth. N Engl J Med 1998;339:313-20.
36. Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents [published erratum appears in Nature 1997;385: 555]. Nature 1996;384:644-8.
37. Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents [published erratum appears in Nature 1997;385: 555]. Nature 1996;384:644-8.
38. Higby K, Xenakis MJ, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety [review]. Am J Obstet Gynecol 1993;168:1247-56; discussion 1256-9.
39. Kragt H, Keirse MJ. How accurate is a woman's diagnosis of threatened preterm delivery? Br J Obstet Gynecol 1990; 77:317-23.
40. Castren O, Gummerus M, Saarikoski S. Treatment of imminent preterm labor: a comparison between the effects of nylidrin chloride and isoxsuprine chloride as well as of ethanol. Acta Obstet Gynecol Scand 1975;54:95-100.
41. Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, et al. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1996;175:1047-53.